Disposition of hexobarbitone in healthy man: kinetics of parent drug and metabolites following oral administration.
Open Access
- 1 April 1983
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 15 (4) , 459-464
- https://doi.org/10.1111/j.1365-2125.1983.tb01530.x
Abstract
1 Hexobarbitone plasma kinetics were determined in six healthy volunteers, who received 500 mg hexobarbitone orally. In addition urinary excretion rate and cumulative excretion were measured of its three major metabolites: 3′-hydroxyhexobarbitone, 3′-ketohexobarbitone and 1,5-dimethylbarbituric acid. 2 The mean plasma elimination half- life of hexobarbitone was 3.7 +/- 0.9 h (n = 6). Assuming complete absorption, the volume of distribution and the metabolic clearance were 81.3 +/- 20.5 1 and 16.4 +/- 2.9 1/h, respectively. The mean maximal plasma concentration was 7.1 +/- 2.1 micrograms/ml and was reached 1.2 +/- 0.4 h after drug administration. 3 3′-Hydroxyhexobarbitone and 3′- ketohexobarbitone, which are products of allylic side-chain oxidation of hexobarbitone, were excreted in 24 h to the extent of 4.7 +/- 1.3 and 32.1 +/- 11.9% of the dose, respectively. In the same period, 1,5- dimethylbarbituric acid, which is the end product of the epoxide-diol pathway, was excreted to 18.0 +/- 7.8% of the dose. The ratio of the sum of 3′-hydroxy- and 3′-ketohexobarbitone vs 1,5-dimethylbarbituric acid excreted varied with time and amounted ultimately in 24 h urine to 2.3 +/- 1.0. 4 The half-lives of 3′-hydroxyhexobarbitone and 1,5- dimethylbarbituric acid, calculated from their renal excretion rate curves, amounted 5.2 +/- 0.9 and 6.6 +/- 1.3 h and were significantly longer than the half-life of hexobarbitone in plasma. The half-life of 3′-ketohexobarbitone was 4.2 +/- 0.8 h. The maximum excretion rate of 1,5-dimethylbarbituric acid was reached at 7.7 +/- 1.0 h after administration of hexobarbitone. 3′-Hydroxy- and 3′-ketohexobarbitone were excreted with a maximal rate at 2.2 +/- 0.8 and 2.8 +/- 0.4 h respectively.This publication has 15 references indexed in Scilit:
- METABOLIC-FATE OF PHENOBARBITAL IN MAN - N-GLUCOSIDE FORMATION1979
- The epoxide-diol pathway in the metabolism of hexobarbital in rat and manXenobiotica, 1979
- Studies on the Different Metabolic Pathways of Antipyrine in Rats: Influence of Phenobarbital and 3-Methylcholanthrene TreatmentXenobiotica, 1979
- Synthesis and acid- and base-catalyzed reactions of hexobarbital 1′,2′-epoxide and heptabarbital 1′,2′-epoxideRecueil des Travaux Chimiques des Pays-Bas, 1979
- The synthesis and urinary estimation of N-hydroxyaprobarbitoneJournal of Pharmacy and Pharmacology, 1978
- Hexobarbital disposition in compensated and decompensated cirrhosis of the liverClinical Pharmacology & Therapeutics, 1978
- Hexobarbital-1′,2′-epoxide: A possible intermediate in the metabolism of hexobarbitalBiochemical Pharmacology, 1978
- Pharmacokinetics of hexobarbital in acute hepatitis and after apparent recoveryClinical Pharmacology & Therapeutics, 1975
- Pharmacokinetics of hexobarbital in man after intravenous infusionJournal of Pharmacokinetics and Biopharmaceutics, 1975
- Rapid and sensitive gas chromatographic determination of hexobarbital in plasma of man using a nitrogen detectorJournal of Chromatography A, 1974